Status:
UNKNOWN
Effectiveness of Light-emitting Diode (LED) Photobiomodulation in the Extraction of Retained Lower Third Molars
Lead Sponsor:
University of Nove de Julho
Conditions:
Pain, Postoperative
Edema
Eligibility:
All Genders
18-35 years
Phase:
PHASE2
Brief Summary
In dentistry, one of the most common surgical procedures is the removal of included third molars. This surgery generates great morbidity to patients for causing pain, edema and trismus due to surgical...
Eligibility Criteria
Inclusion
- Patients who need surgical removal of retained lower third molars;
- Patients who agree to participate in the study after reading and signing the Term of Consent for Participation in Clinical Research.
- Patients with indication for extraction of lower third molars (recurrent infections, bad position, orthodontic indication) or written professional indication (ASA I - negative medical history), systolic blood pressure less than 140mmHg, and diastolic blood pressure lower than 90mmHg and heart rate values of 70 ± 20 beats / minute and have the upper and lower central incisor teeth.
Exclusion
- Patients who have systemic diseases, chronic pain or neurological and psychiatric disorders;
- Claim to be smokers;
- Are using anti-inflammatories, analgesics or bisphosphonates in the last 15 days;
- Present active pericoronaritis;
- Are pregnant;
- are breastfeeding;
- Severe temporomandibular disorders
- Have photo sensitivity history
- Are allergic to any drug used in the research (paracetamol, chlorhexidine 2%)
- Patients presenting radiolucent images associated with the teeth to be extracted
- Patients who present any type of complication during surgery (hemorrhage, operative difficulty, time greater than 90 minutes of surgery), as these cases are not in the standard expected for third molar surgeries. In this case the central action analgesic will be prescribed. These data will not be part of the statistical analysis but will be described and discussed as well as possible adverse effects.
Key Trial Info
Start Date :
September 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT03442166
Start Date
September 1 2018
End Date
December 31 2019
Last Update
October 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UniNove
São Paulo, São Paulo, Brazil, 01504-000